Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy.
J Cell Physiol. 2018 Apr;233(4):3306-3314. doi: 10.1002/jcp.26177. Epub 2017 Sep 28.
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (HMGCS2) catalyses the first step of ketogenesis and is critical in various metabolic conditions. Several nutrient molecules were able to differentially modulate HMGCS2 expression levels. Docosahexaenoic acid (DHA, C22:6, n-3), eicosapentaenoic acid (EPA, C20:5, n-3), arachidonic acid (AA, C20:4, n-6), and glucose increased HMGCS2 mRNA and protein levels in HepG2 hepatoma cells, while fructose decreased them. The effect of n-6 AA resulted significantly higher than that of n-3 PUFA, but when combined all these molecules were far less efficient. Insulin reduced HMGCS2 mRNA and protein levels in HepG2 cells, even when treated with PUFA and monosaccharides. Several nuclear receptors and transcription factors are involved in HMGCS2 expression regulation. While peroxysome proliferator activated receptor α (PPAR-α) agonist WY14643 increased HMGCS2 expression, this treatment was unable to affect PUFA-mediated regulation of HMGCS2 expression. Forkhead box O1 (FoxO1) inhibitor AS1842856 reduced HMGCS2 expression and suppressed induction promoted by fatty acids. Cells treatment with liver X receptor alpha (LXRα) agonist T0901317 reduced HMGCS2 mRNA, indicating a role for this transcription factor as suppressor of HMGCS2 gene. Previous observations already indicated HMGCS2 expression as possible nutrition status reference: our results show that several nutrients as well as specific nutritional related hormonal conditions are able to affect significantly HMGCS2 gene expression, indicating a relevant role for PUFA, which are mostly derived from nutritional intake. These insights into mechanisms of its regulation, specifically through nutrients commonly associated with disease risk, indicate HMGCS2 expression as possible reference marker of metabolic and nutritional status.
线粒体 3-羟基-3-甲基戊二酰辅酶 A(HMG-CoA)合酶(HMGCS2)催化酮体生成的第一步,在各种代谢条件下都很关键。几种营养分子能够差异调节 HMGCS2 的表达水平。二十二碳六烯酸(DHA,C22:6,n-3)、二十碳五烯酸(EPA,C20:5,n-3)、花生四烯酸(AA,C20:4,n-6)和葡萄糖增加 HepG2 肝癌细胞中的 HMGCS2 mRNA 和蛋白水平,而果糖则降低其水平。n-6 AA 的影响明显高于 n-3 PUFA,但当结合所有这些分子时,效果要差得多。胰岛素降低 HepG2 细胞中的 HMGCS2 mRNA 和蛋白水平,即使在 PUFA 和单糖存在的情况下也是如此。几种核受体和转录因子参与 HMGCS2 的表达调控。过氧化物酶体增殖物激活受体 α(PPAR-α)激动剂 WY14643 增加 HMGCS2 的表达,但这种治疗方法不能影响 PUFA 对 HMGCS2 表达的调节。叉头框 O1(FoxO1)抑制剂 AS1842856 降低 HMGCS2 的表达,并抑制脂肪酸诱导的表达。用肝 X 受体 α(LXRα)激动剂 T0901317 处理细胞,降低 HMGCS2 mRNA,表明该转录因子作为 HMGCS2 基因的抑制因子。先前的观察结果已经表明 HMGCS2 的表达可以作为营养状况的参考:我们的结果表明,几种营养物质以及特定的与营养相关的激素条件能够显著影响 HMGCS2 基因的表达,表明 PUFA 具有重要作用,而 PUFA 主要来自营养摄入。这些对其调控机制的深入了解,特别是通过与疾病风险相关的常见营养素,表明 HMGCS2 的表达可能是代谢和营养状况的参考标志物。